Remplir™ Study Delivers Compelling 81% Success Rate
Data to support US sales roll out and EU + UK regulatory submissions
- Interim results from a new Remplir™ study demonstrated a compelling overalltreatment success rate of 81.1%following nerve repair procedures.
- Real World Evidence (RWE) patient data collected in the study confirms Orthocell's nerve repair product, Remplir, as the...
Read more: Remplir™ Study Delivers Compelling 81% Success Rate